AI Generated Image
Blood pressure medication recalled for potential ineffectiveness
KCTV • • business
Key Points:
- The FDA has recalled 11,460 bottles of chlorthalidone tablets, USP, 25 mg, due to failed dissolution specifications, which may render the medication ineffective.
- The recall includes 100-tablet bottles from batch RISA24001 and 1,000-tablet bottles from batch RISB24002.
- The affected medication has an expiration date of April 2027.
- This recall is significant for patients relying on this blood pressure medication to manage their condition.
